| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/09/2006 | CN1813755A Aminophylline dropping pill and its preparing method |
| 08/09/2006 | CN1813754A Diprophylline dropping pill and its preparing method |
| 08/09/2006 | CN1813739A Nalmefene hydro chloride lyophilized powder formulation for injection |
| 08/09/2006 | CN1813734A Procaterol hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813717A Use of 1-methyl hydrantoin for preparing medicine for relieving cough and asthma, and eliminating sputum |
| 08/09/2006 | CN1813696A Levalbuterol slow-release tablet and its preparing method |
| 08/09/2006 | CN1813695A Terbutaline sulfate dropping pill and its preparing method |
| 08/09/2006 | CN1813694A Clenbuterol hydrochloride dropping pill and its preparing method |
| 08/09/2006 | CN1813690A Asarone injection emulsion and its preparing method |
| 08/09/2006 | CN1813689A Asarone fatty emulsion and its preparing method |
| 08/09/2006 | CN1813686A Montelukast oral disintegrating tablet formulation and its preparing method |
| 08/09/2006 | CN1813685A Couted particle for reinforcing pidotimod acid-base stability, and its production method and use |
| 08/09/2006 | CN1813680A Isepamicin sulfate powder for injection and its preparing method |
| 08/09/2006 | CN1813673A Isepamicin sulfate formulation for intravenous administration and its preparing method |
| 08/09/2006 | CN1813601A Cigarette filter tip additive capable of reducing smoke harmful effect to respiratory system |
| 08/09/2006 | CN1268644C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline E to its high affinity receptor |
| 08/09/2006 | CN1268643C Antibody against SARS-CoV IgY and its preparing method |
| 08/09/2006 | CN1268625C Cyclic amp-specific phosphodiesterase inhibitors |
| 08/09/2006 | CN1268623C Novel composition and method or stabilizing same |
| 08/09/2006 | CN1268360C Pathogenic fire purging Chinese medicinal tablet containing borneol and nantura oindigo and preparation method thereof |
| 08/09/2006 | CN1268328C Coenzyme q and eicosapentaenoic acid (EPA) |
| 08/09/2006 | CN1268327C Brufen arginine pseudoephedrine hydrochloride compound formulation |
| 08/08/2006 | US7087759 for controlling weight; pyrrolidine or piperidine compounds |
| 08/08/2006 | US7087642 Inhibitors of IMPDH enzyme |
| 08/08/2006 | US7087634 Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/08/2006 | US7087631 Aryltetrazole compounds, and compositions thereof |
| 08/08/2006 | US7087624 Substituted pyrazole compounds |
| 08/08/2006 | US7087614 Pyrimidine inhibitors of phosphodiesterase (PDE) 7 |
| 08/08/2006 | US7087607 Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |
| 08/08/2006 | US7087605 5-Ethyl-imidazotriazinones |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/08/2006 | US7087597 Pyrimidine 5-carboxamide compounds, process for producing the same and use thereof |
| 08/08/2006 | US7087595 Antihistaminic spiro compounds |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087432 Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof |
| 08/08/2006 | US7087253 Pharmaceutical composition, comprising eucalyptus oil and orange oil |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/03/2006 | WO2006081431A2 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | WO2006081343A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 08/03/2006 | WO2006080884A1 Novel biaromatic compounds, inhibitors of the p2x7-receptor |
| 08/03/2006 | WO2006080582A1 Agent for control of function of antigen-presenting cell |
| 08/03/2006 | WO2006080287A1 2-azolylimino-1,3-thiazine derivative |
| 08/03/2006 | WO2006080284A1 2-substituted imino-1,3-oxazine derivative |
| 08/03/2006 | WO2006079841A1 Nebulizer formulation |
| 08/03/2006 | WO2006079624A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/03/2006 | WO2006079290A1 A recombinant sars-cov vaccine comprising attenuated vaccinia virus carriers |
| 08/03/2006 | WO2006079209A1 Pulmonary compositions comprising a vitamin a compound and a surfactant and uses thereof |
| 08/03/2006 | WO2006064015A3 Diphenylurea derivatives useful as potassium channel activators |
| 08/03/2006 | WO2006061418A3 Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion |
| 08/03/2006 | WO2006057932A3 2-METHYLENE-18,19-DINOR-1α-HYDROXY-HOMOPREGNACALCIFEROL AND ITS USES |
| 08/03/2006 | WO2006050734A3 Potent lna oligonucleotides for the inhibition of hif-1a expression |
| 08/03/2006 | WO2006044421A3 Cardiac safe, rapid medication delivery |
| 08/03/2006 | US20060173079 Compositions and methods for improving the condition of patients suffering from copd and other diseases |
| 08/03/2006 | US20060173034 Novel 4-anilinoquinoline-3-carboxamides |
| 08/03/2006 | US20060173003 4-Heteroarylamino-7-H(hetero)aryl-substituted, e.g., [6-(propane-2-sulfonyl)-pyridin-3-yl]-[7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-4-yl ]-amine hydrochloride; the compounds inhibit binding of vanilloid ligands to capsaicin receptors and are used to treat neuropathic pain |
| 08/03/2006 | US20060172988 Azetidine compounds |
| 08/03/2006 | US20060171934 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 08/03/2006 | CA2596215A1 Nebulizer formulation of levalbuterol and ipratropium |
| 08/03/2006 | CA2596144A1 Compounds for treating inflammatory and demyelinating diseases |
| 08/03/2006 | CA2595875A1 Methods of diagnosis and treatment for asthma, allergic rhinitis and other respiratory diseases based on haplotype association |
| 08/03/2006 | CA2595728A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 08/03/2006 | CA2592608A1 Metabolites of 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| 08/03/2006 | CA2567789A1 Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist |
| 08/02/2006 | EP1686130A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents |
| 08/02/2006 | EP1685830A1 Plaster |
| 08/02/2006 | EP1685118A2 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 08/02/2006 | EP1684767A1 Soft steroid compositions for use in dry powder inhalers |
| 08/02/2006 | EP1684719A2 Alpha 1-antitrypsin compositions and treatment methods using such compositions |
| 08/02/2006 | EP1684717A2 Pharmaceutical aerosol compositions |
| 08/02/2006 | EP1684711A2 Composition |
| 08/02/2006 | EP1684690A2 Methods of using and compositions comprising a jnk inhibitor for the treatment and management of asbestos-related diseases and disorders |
| 08/02/2006 | EP1496882B1 Tolterodine salts |
| 08/02/2006 | EP1430050B1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 08/02/2006 | EP1412362B1 THIENO¬2,3-d|PYRIMIDINEDIONES AS INHIBITORS OF T-CELLS PROLIFERATION |
| 08/02/2006 | EP1267828B1 Pharmaceutical preparations containing saccharose fatty acid esters for controlling the release of active ingredients |
| 08/02/2006 | EP1030662B1 Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists |
| 08/02/2006 | CN1812974A N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
| 08/02/2006 | CN1812973A Indazole compounds useful as protein kinase inhibitors |
| 08/02/2006 | CN1812796A Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale |
| 08/02/2006 | CN1810822A 2-aminocarbonyl-9h-purine derivatives |
| 08/02/2006 | CN1810809A Coumarether compound and new use of its composition |
| 08/02/2006 | CN1810777A Compound for preventing and treating bacterial infection and its prepn and use |
| 08/02/2006 | CN1810288A Nosebleeding treating glutinous rehmannia bolus |
| 08/02/2006 | CN1810286A Externally applied plaster |
| 08/02/2006 | CN1810285A Recipe and prepn of medicine for relieving asthma and cough |
| 08/02/2006 | CN1810275A Pharyngitis treating ointment |
| 08/02/2006 | CN1810273A Rhinitis treating ointment |
| 08/02/2006 | CN1810272A Prepn process of red sage prepn and its quality control method |
| 08/02/2006 | CN1810266A Saliva secretion promoting prepn and its prepn process and application |
| 08/02/2006 | CN1810264A Jindongling medicine |
| 08/02/2006 | CN1810246A Nasal in-situ gel of scopolamine with phase change property |
| 08/02/2006 | CN1810240A Prepn process and use of total andrographolide emulsion |
| 08/02/2006 | CN1810237A Slow-released ambroxol salt tablet and its prepn process |
| 08/02/2006 | CN1267423C Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists |
| 08/02/2006 | CN1267412C CCR-3 receptor antagonists V |
| 08/02/2006 | CN1267394C Vitamin D analogues |
| 08/02/2006 | CN1267120C Frozen dry powder injection of houttuynia cordata and its preparation |
| 08/02/2006 | CN1267112C Medicinal composition for preventing and curing dyspneic cough and pulmonary emphysema and its preparing method |
| 08/02/2006 | CN1267098C Usage of treating allergic rhinitis and other disorders using descarboethoxyloratadine |